Company Filing History:
Years Active: 2024-2025
Title: Hee-Kyung Na: Innovator in Biomolecular Detection
Introduction
Hee-Kyung Na is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biomolecular detection, holding 2 patents that showcase his innovative approaches. His work primarily focuses on enhancing the sensitivity and specificity of biomolecule detection methods.
Latest Patents
One of his latest patents is a "Method for high-sensitivity and high-specificity detection of biomolecules by using mass spectrometry." This invention relates to a method that enables the detection of proteins such as miRNA or antigens with high sensitivity and specificity. It utilizes advanced techniques like time-of-flight secondary ion mass spectrometry (ToF-SIMS), matrix-assisted laser desorption/ionization (MALDI), and laser desorption/ionization (LDI) mass spectrometry. This method is expected to play a crucial role in disease diagnosis and prediction by quantifying disease markers from biosamples.
Another notable patent is the "Method for measuring organic matter in blood by using LDI-MS, and device therefor." This invention simplifies the measurement process of organic matter in blood, allowing for real-time analysis and result collection. It boasts excellent sensitivity and accuracy, enabling the detection of various organic compounds simultaneously without interference from the matrix.
Career Highlights
Hee-Kyung Na has worked with esteemed institutions such as the Korea Research Institute of Standards and Science and the Korea Advanced Institute of Science and Technology. His experience in these organizations has significantly contributed to his expertise in mass spectrometry and biomolecular analysis.
Collaborations
He has collaborated with notable colleagues, including Tae Geol Lee and Sunho Joh, who have contributed to his research endeavors.
Conclusion
Hee-Kyung Na's innovative work in biomolecular detection through mass spectrometry has the potential to revolutionize disease diagnosis and monitoring. His contributions reflect a commitment to advancing scientific knowledge and improving healthcare outcomes.